Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study-Reference-Cited by-同舟云学术

Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study

Published:2013-06-26 Issue:10 Volume:49 Page:839-844
ISSN:1034-4810
Container-title:Journal of Paediatrics and Child Health
language:en
Short-container-title:J Paediatr Child Health

Author:

Paul Saritha¹²³,Rao Shripada¹²³,Kohan Rolland¹³,McMichael Judy¹²,French Noel¹³,Zhang Guicheng⁴,Simmer Karen¹²³

Affiliation:

1. Department of Neonatology; King Edward Memorial Hospital for Women; Western Australia Australia

2. Department of Neonatology; Princess Margaret Hospital for Children; Perth Western Australia Australia

3. Centre for Neonatal Research and Education; School of Paediatrics and Child Health; University of Western Australia; Perth Western Australia Australia

4. Department of Statistics; Princess Margaret Hospital for Children; Perth Western Australia Australia

Publisher

Wiley

Subject

Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jpc.12300/fullpdf

Reference25 articles.

1. Animal derived surfactant extract for treatment of respiratory distress syndrome;Seger;Cochrane Database Syst. Rev.,2009

2. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome;Soll;Cochrane Database Syst. Rev.,2001

3. Surfactant replacement therapy in preterm infants: a European survey;Kaam;Neonatology,2011

4. History of surfactant from 1980;Halliday;Biol. Neonate,2005

5. CRIB II: an update of the clinical risk index for babies score;Parry;Lancet,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of porcine versus bovine surfactant in preterm respiratory distress syndrome: Evidence from real‐world data. A multicentre collaboration from Karnataka;Pediatric Pulmonology;2024-04-25

2. Comparison of efficacy between beractant and poractant alfa in respiratory distress syndrome among preterm infants (28–33+6 weeks gestational age) using the less invasive surfactant administration (LISA) technique: A randomized controlled trial;Journal of Perinatology;2024-04-12

3. Comparison of efficacy between beractant and poractant-alfa in respiratory distress syndrome among preterm infants (28-33+6 weeks gestational age) using the less invasive surfactant administration (LISA) technique: A randomized controlled trial;2024-01-25

4. Nanotoxicological profiles of clinically approved nanoplatforms;Beni-Suef University Journal of Basic and Applied Sciences;2023-12-16

5. Comparing the clinical and economic efficiency of four natural surfactants in treating infants with respiratory distress syndrome;PLOS ONE;2023-06-30